Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight across pharmaceutical and food supply chains, with new enforcement actions against substandard products, blacklisting of foreign suppliers, and expanded stakeholder training requirements. For Nigerian SMBs in healthcare, pharmaceuticals, and related distribution, this means stricter compliance expectations and heightened risk of penalties for non-compliant products. Businesses should urgently verify product authenticity and supplier legitimacy to avoid regulatory action.
Pharmaceuticals and healthcare
Food and drug importation
Distribution and retail (including PPMVs)
Clinical trials and research
Export agriculture (fish farming)
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to strengthen regulatory and pharmacovigilance capacity across Nigeria.
SMBs in pharmaceutical retail and distribution may see increased inspections and support for compliance, but also more scrutiny of product handling and reporting.
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC rescheduled mandatory training on clinical trial regulations for stakeholders, indicating updated compliance requirements for clinical research.
SMBs involved in clinical trials, CROs, and research-based pharma must ensure staff attend training to remain compliant and avoid penalties.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC blacklisted Ayrtons Saunders Ltd, UK, and its products, prohibiting importation, distribution, or sale in Nigeria.
SMB importers and distributors must immediately stop handling any products from this company and verify supplier legitimacy to avoid confiscation and legal action.
Public Alert No. 043/2026: NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation, urging stakeholders to exercise caution.
Retailers, distributors, and PPMVs should quarantine and report any Mofus products, and may face penalties if they continue to sell them.
Public Alert No. 042/2026: Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC seized a suspected substandard and falsified antimalarial medicine, BPPL Artemether/Lumefantrine 80mg/480mg, and alerted healthcare providers and the public.
Pharmacy owners, PPMVs, and distributors must immediately remove this product from shelves and verify all antimalarial stock to protect customers and avoid regulatory sanctions.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with the Nigerian Export Promotion Council (NEPC) for export purposes was published.
SMBs in aquaculture seeking to export can use this guide to navigate registration, potentially unlocking new revenue streams and compliance with export standards.
Increased NAFDAC enforcement against substandard and falsified drugs means higher risk for pharmacies and distributors selling unverified products.
Blacklisting of foreign suppliers signals need for rigorous due diligence in import supply chains.
Mandatory clinical trial training indicates tightening regulation for research-based SMBs.
Pharmacist reserve group may lead to more frequent inspections and support for compliance.
Export opportunities for fish farmers through NEPC registration, but requires adherence to quality and export regulations.
1
Immediately check inventory for any products from Ayrtons Saunders Ltd, Mofus Nigeria Ltd, or the seized BPPL Artemether/Lumefantrine batch, and quarantine or return them.
2
Verify all pharmaceutical and food product suppliers are NAFDAC-registered and products have valid NAFDAC numbers.
3
Register for and attend NAFDAC/NHREC mandatory clinical trial training if involved in clinical research.
4
Conduct staff training on identifying substandard and falsified medicines and reporting to NAFDAC.
5
For fish farmers, initiate NEPC registration process to access export markets and comply with export guidelines.
6
Monitor NAFDAC public alerts and watchlists regularly to stay updated on banned or risky products.